{"created_at":"Thu Dec 10 13:02:06 +0000 2015","id":674937132050456576,"id_str":"674937132050456576","text":"#Pfizer : Announces FDA Acceptance of IBRANCE\u00ae (palbociclib) Supplemental New ... https:\/\/t.co\/VnKXroCi35 $PFE","source":"\u003ca href=\"http:\/\/test.zonebourse.com\" rel=\"nofollow\"\u003eZonebourse Communaut\u00e9\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":102325185,"id_str":"102325185","name":"4-traders.com","screen_name":"ForTraders","location":null,"url":"http:\/\/www.4-traders.com","description":null,"protected":false,"verified":false,"followers_count":6605,"friends_count":65,"listed_count":474,"favourites_count":0,"statuses_count":838094,"created_at":"Wed Jan 06 09:33:43 +0000 2010","utc_offset":-18000,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/643561384\/logo_twitter_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/643561384\/logo_twitter_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"is_quote_status":false,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"Pfizer","indices":[0,7]}],"urls":[{"url":"https:\/\/t.co\/VnKXroCi35","expanded_url":"http:\/\/www.4-traders.com\/PFIZER-INC-23365019\/news\/Pfizer--Announces-FDA-Acceptance-of-IBRANCE-palbociclib-Supplemental-New-Drug-Application-with-P-21537941\/","display_url":"4-traders.com\/PFIZER-INC-233\u2026","indices":[82,105]}],"user_mentions":[],"symbols":[{"text":"PFE","indices":[106,110]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1449752526663"}
